Download in electronic PDF format for $25

Search the Complete Journal Archives

Stability of Prednisone in Oral Mix Suspending Vehicle

Author(s):  Friciu Mihaela,Plourde Kevin,Leclair Grégoire,Danapoulos Panagiota,Savji Taslim

Issue:  Jul/Aug 2015 - Volume 19, Number 4
View All Articles in Issue

Abstract:  The stability of prednisone (5 mg/mL) formulated as a suspension in Oral Mix vehicle was evaluated. Oral Mix is a novel oral, dye-free suspending vehicle developed by Medisca Pharmaceutique Inc. for preparation of extemporaneous dosage forms. This drug was chosen based on its high frequency of prescription among the pediatric population. Suspensions were prepared from both pure active and commercial tablets utilizing two different container closures: amber glass bottles and polypropylene syringes (PreciseDose Dispenser Medisca Pharmaceutique Inc.). Formulations were stored at 5°C or 25°C and organoleptic properties, pH, and concentration were evaluated at predetermined time points up to 90 days. Validated stability-indicating high-performance liquid chromatography methods were developed. Beyond-use date was evaluated by statistical analysis of the overall degradation trend. Prednisone was stable for at least 90 days at 25°C. No changes in organoleptic properties or pH were observed for either of the formulations, and the global stability was roughly equivalent and sometimes superior to the stability of the same drugs in other previously used vehicles. Thus, Oral Mix was found to be a suitable dye-free vehicle for extemporaneous formulations.

Related Keywords: Mihaela Friciu, MSc, Kevin Plourde, BSc, Grégoire LeClair, BPharm, PhD, Panagiota Danapoulos, BSc, Taslim Savji, BSc, prednisone, oral suspension vehicle, Oral Mix, storage, stability, children, excipients


Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Stability of Prednisone in Oral Mix Suspending Vehicle Friciu Mihaela, Plourde Kevin, Leclair Grégoire, Danapoulos Panagiota, Savji Taslim Jul/Aug 2015 337-339 Buy
Stability of Venlafaxine Immediate-Release Suspensions Donnelly Ronald F, Wong Keith, Goddard Rob, Johanson Christel Jan/Feb 2011 81-84 Buy
Oral Liquid Vehicles, Featured Excipient: Allen Loyd V Jr Jan/Feb 2001 65 Buy
Standards of Practice, Professional Judgment, and Scientific Evidence to Establish and Extend a Beyond-Use Date Thomson Cassandra Marie, Savji Taslim Nov/Dec 2014 456-460 Buy
Stability of Alprazolam, Atropine Sulfate, Glutamine, Levofloxacin, Metoprolol Tartrate, Nitrofurantoin, Ondansetron Hydrochloride, Oxandrolone, Pregabaline, and Riboflavin in SyrSpend SF pH4 Oral Suspensions de Oliveira Ferreira Anderson, Polonini Hudson C, Loures da Silva Sharlene, Cerqueira de Melo Victor Augusto, de Andrade Laura, Fernandes Brandão Marcos Antônio May/Jun 2017 255-263 Buy
In Vitro Evaluation of Extemporaneously Compounded Immediate-release Capsules with Premixed Excipients, Based on the Biopharmaceutics Classification System (BCS) of the Drugs Pinheiro Vanessa A, Danopoulos Panagiota, Demirdjian Lara, Nogueira Rodrigo J L, Dubois Fanny Sep/Oct 2013 424-431 Buy
Antimicrobial Activity of Copaiba (Copaifera officinalis) and Pracaxi (Pentaclethra macroloba) Oils against Staphylococcus aureus: Importance in Compounding for Wound Care Guimarães Anna Luísa Aguiar, Cunha Elisa Alves, Matias Fernanda Oliveira, Garcia Patrícia Guedes, Danopoulos Panagiota, Swikidisa Rosita, Pinheiro Vanessa Alves, Nogueira Rodrigo José Lupatini Jan/Feb 2016 58-62 Buy
Women's Oral Health: Is There a Hormonal Link? Preckshot John Jan/Feb 2004 10 Buy
Room Temperature Stability of Injectable Succinylcholine Dichloride Roy Julie J, Boismenu Daniel, Mamer Orval A, Nguyen Bao T, Forest Jean-Marc, Hildgen Patrice Jan/Feb 2008 83-85 Buy
Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children Pramann Lance A, Davidow Lawrence W, van Haandel Leon, Funk Ryan S May/Jun 2016 257-261 Buy